TreatmentTrends®: US Nephrology Q3’10

A Quarterly Report Package Providing Insight into the Management of Patients Across the Spectrum of Chronic Kidney Disease

Study Overview:

TreatmentTrends are syndicated reports that provide longitudinal information on market dynamics. This series of four reports provides insight into practice patterns, attitudes and perceptions, current product use and future projections. It evaluates perceived product advantages and disadvantages, as well as sales and marketing efforts of key players. Emphasis is on anemia management (ESAs and Iron), calcium-phosphorus metabolism, and secondary hyperparathyroidism in patients with CKD Stages 3 and 4, as well as patients on dialysis.

Methodology:

Physicians complete a self-administered internet survey. The methodology is quantitative with several open-ended questions for qualitative feedback.

Sample Frame:

Each report will highlight responses from a random sample of 200 board-certified Nephrologists - 100 completing the anemia section and 100 completing the bone and mineral metabolism section. The final (fourth quarter) report will survey 300+ Nephrologists for a projectable sample. All participating Nephrologists will have at least 100 CKD Stage 3/4 patients and/or 50 Dialysis patients.

Timing:

TreatmentTrends in Nephrology is fielded and published quarterly. 2010 Publication dates are: April 12, July 12, October 11, and December 31st.

Deliverables:

In addition to the final report following each wave, a complete set of frequency tables, summary statistics, and cross-tabulations will be provided. Clients will also receive a customized report with information from their proprietary questions (each client has the option to include up to three proprietary questions). Onsite or web-cast presentations are available upon request at no charge.